You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Interleukin Genetics said Monday that it plans to liquidate its assets three weeks after it announced it was laying off 63 percent of its workforce and suspending sales of its controversial genetic test for severe gum disease and elevated systemic inflammation.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.